Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hypoglycemia
Phenotype |diabetes
Sentences 306
PubMedID- 24548693 Aims: the global attitude of patients and physicians 2 (gapp2) survey sought to address gaps in understanding about real-world basal insulin-taking behaviour and self-treated hypoglycaemia in patients with type 2 diabetes mellitus.
PubMedID- 23916172 Conclusions: the document provides evidence-based practical recommendations for evaluation and management of hypoglycemia in patients with diabetes mellitus.
PubMedID- 25647516 This study describes demographic characteristics, comorbidities, and hypoglycemia events in patients with type 2 diabetes mellitus (t2dm) identified using 2011 medicare 5% standard analytical files.
PubMedID- 23148173 The overwhelming majority of occurrences of hypoglycaemia occur in patients with diabetes, either as a result of treatment-induced hypoglycaemia and/or abnormalities that affect the normal counterregulatory response to hypoglycaemia.
PubMedID- 25349949 Conclusion: depression in type 2 diabetes was closely associated with hyperglycemia and hypoglycemia, which might be partly mediated through poor treatment adherence.
PubMedID- 23555895 Recurrent hypoglycemia in diabetes occurs due to the interplay between therapeutic hyperinsulinemia and compromised counterregulatory and symptom responses to falling plasma glucose levels.
PubMedID- 24589650 Objectives: the aim of this study was to investigate specific fears related to hypoglycemia in adults with type 1 diabetes and to investigate how aspects of fear of hypoglycemia may differ between genders.
PubMedID- 20668157 The effect of fasting during ramadan on rates of hypoglycemia in patients with diabetes is not known with certainty.
PubMedID- 25070348 Conclusion: in conclusion candesartan has no effect on cerebral function during mild experimental hypoglycaemia in subjects with type 1 diabetes and high ras activity.
PubMedID- 24286945 This article summarizes our current knowledge of the epidemiology, pathogenesis, risk factors, and complications of hypoglycemia in patients with diabetes and discusses prevention and treatment strategies.
PubMedID- 23950905 Fear of hypoglycaemia amongst patients with diabetes has been reported to be as great as that of blindness and renal failure [3].
PubMedID- 25354740 Formulation of cores for the controlled release of glucose for prevention of hypoglycemia in diabetes patients.
PubMedID- 21216859 Overnight use improved glucose control and reduced hypoglycemia in children with type 1 diabetes (18).
PubMedID- 25030524 Conclusion: the effects of experiences of frequent and severe hypoglycemia in patients with diabetes emphasize the need for programs that support diabetes-specific self-efficacy and also guide and teach hypoglycemia prevention.
PubMedID- 25267512 Recurrent nocturnal hypoglycemia in a patient with type 1 diabetes mellitus.
PubMedID- 22675341 Due to this properties, the hormone reduces hyperglycemia without inducing hypoglycemia in patients with type 2 diabetes [3].
PubMedID- 25764474 Fear of hypoglycaemia in adults with type 1 diabetes: results from diabetes miles - the netherlands.
PubMedID- 23846941 Context: allotransplantation of islets can successfully treat subjects with type 1 diabetes complicated by severe hypoglycemia and erratic glycemic control.
PubMedID- 23100048 The risk factors for hypoglycemia in diabetes in general (use of insulin or insulin secretagogues, duration of diabetes, antecedent hypoglycemia, erratic meals, exercise, renal insufficiency) (104) presumably apply to older patients as well.
PubMedID- 25683747 Conclusions: a weight-based protocol of 0.3 g/kg glucose appears more effective for treating symptomatic hypoglycaemia in adults with type 1 diabetes than either the most common current recommendation of 15 g glucose or a 0.2 g/kg glucose dose.
PubMedID- 22446170 Effects of dapagliflozin, an sglt2 inhibitor, on hba(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy.
PubMedID- 24264400 hypoglycemia in diabetes is typically the result of the interplay of therapeutic insulin excess—caused by treatment with insulin, a sulfonylurea, or a glinide—and compromised physiological and behavioral defenses against falling plasma glucose concentrations (1,2).
PubMedID- 21499675 Aims/hypothesis: severe hypoglycaemia associated with diabetes management is a potential risk for cardiovascular diseases.
PubMedID- 21323815 Improvements in real-time continuous glucose monitoring and optimisation of basal insulin dosing may offer significant benefit to preventing hypoglycaemia in patients with type 1 diabetes who regularly exercise.
PubMedID- 21951832 As the act of fasting increases the risk of hypoglycaemia in patients with diabetes, in part related to potentially impaired counter-regulatory responses to low blood glucose (1), treatment guidelines recommend that most patients with diabetes should not fast during ramadan (2,3).
PubMedID- 25927986 These divergent findings are consistent with recent literature describing differences between patients with vs. without diabetes regarding the relationships of hyperglycemia, hypoglycemia and glucose variability to mortality [23-25].
PubMedID- 25599725 The most common instrument for assessing the fear of hypoglycemia among adults with diabetes is the hypoglycemia fear survey (hfs) [4, 5].
PubMedID- 22371733 The most frequent causes of hypoglycaemia in patients with type 2 diabetes treated with oral hypoglycaemic agents are: dose not adjusted for meals and physical activity, renal and/or hepatic dysfunction, administration of certain drugs (β-blockers, ace inhibitors, sulphonamides) and alcohol consumption.
PubMedID- 24909093 Glucagon on recovery from controlled insulin-induced hypoglycaemia in patients with type 2 diabetes treated with the novel glucokinase activator azd1656, in combination with metformin.
PubMedID- 21246008 In other words, normal blood glucose regulation is becoming the limiting factor in hypoglycemia in patients with diabetes [2].
PubMedID- 24607084 The questionnaire included also self-reported questions related to nutritional factors associated with diet in daily clinical practice such as if the patient followed any prescribed diet, the specific health care professional that prescribed the diet, how adherent to the reported diet patients were (it is of note that adherence was defined as following at least 80% of the time of the reported diet), type of reported diet, main difficulties found to follow the diet, presence of comorbidities, self-reported frequency of severe hypoglycemia and hospitalization because of either diabetes ketoacidosis or hyperglycemia.
PubMedID- 20137086 These neurofunctional deficits are one of the key contributors to motor deficits and cellular stress associated with hypoglycemia in diabetes which is suggested to cause more damage at molecular level than hyperglycemia.
PubMedID- 22391950 And, in particular,does resistance or endurance exercising bear a greater risk of hypoglycaemia in humans with type 2 diabetes on oral glucose-lowering drugs or on insulin?
PubMedID- 25922810 However, the effect of structured education on the prevention of hypoglycemia in patients with type 2 diabetes has not been well studied.
PubMedID- 21443586 Objective: to determine the most effective of four oral treatments for hypoglycemia in children with type 1 diabetes using a weight-based protocol during diabetes camp.
PubMedID- 21691469 Of the conditions listed, six are known causes of aloc: stroke/transient ischemic attack (tia), diabetes (due to episodes of hypoglycemia), alcohol use, psychiatric illness, illicit drug use and seizures.11,12 we excluded trauma patients with aloc from our analysis.
PubMedID- 22417321 Conclusions: rates of severe hypoglycaemia in youth with type 1 diabetes remain high.
PubMedID- 22998689 Learning and memory deficits are common neurological sequelae following hypoglycemia in patients with type 1 diabetes and in the relatively younger population with type 2 diabetes [49-51].
PubMedID- 25806359 We describe a case with type 2 diabetes who complained of episodes of recurrent hypoglycaemia in last few weeks.
PubMedID- 25316712 Minimizing the occurrence of hypoglycemia in patients with type 2 diabetes is a challenging task since these patients typically check only 1 to 2 self-monitored blood glucose (smbg) readings per day.
PubMedID- 22855730 The clinical use of the glp-1 receptor agonist exenatide (byetta) has not been associated with significant hypoglycemia in patients with diabetes, except when given concomitantly with sulfonylureas (18).
PubMedID- 20307408 All of these aspects can be affected adversely by diabetes per se, with hypoglycemia being the main concern for people with diabetes who drive.
PubMedID- 26152103 Background: hypoglycemia is concerning in patients with diabetes undergoing hyperbaric oxygen (hbo2) therapy.
PubMedID- 22611064 Conclusions: spontaneous nocturnal hypoglycemia in patients with type 1 diabetes results in a reduction of the low-frequency component of hr, which is best explained by excessive sympathetic activation without a concomitant withdrawal of vagal outflow.
PubMedID- 23735724 Provided the growing concerns for the increased mortality in intensively managed type 2 diabetes (38,39), the detection of asymptomatic hypoglycemia may be an additional advantage of structured smbg.
PubMedID- 24397859 Four patients had the diagnosis of diabetes on admission with hypoglycemia not being implicated in any cases.
PubMedID- 22316089 Background: the efficacy of automatic suspension of insulin delivery in induced hypoglycemia among subjects with type 1 diabetes was evaluated.
PubMedID- 23264422 A large cohort study suggested that among older adults with type 2 diabetes, a history of severe hypoglycemia was associated with greater risk of dementia (224).
PubMedID- 26455870 The risk of hypoglycaemia increased with diabetes duration, presence of diabetes-related complications, use of self-monitoring blood glucose, insulin secretagogues, and insulin treatment.
PubMedID- 23209068 The underlying pathophysiologies that link diabetes and development of ad are, recurrent hypoglycemia, antioxidative stress due to hyperglycemia, atherosclerosis and vascular lesions, and abnormal insulin signaling in the brain.

Page: 1 2 3 4 5 6 7